CTA Group

CTA (Clinical Trial Assistance), often referred to as CTA Group, is a specialized service provider in the clinical trial supply chain sector. The company focuses on the strategic sourcing of comparator drugs, rescue medications, and ancillary supplies for global clinical trials. CTA provides comprehensive solutions including procurement, regulatory support, and logistical management to ensure that clinical trial sites receive necessary medications and materials efficiently. In April 2023, CTA was acquired by Myonex, a global leader in clinical trial supply, to expand its sourcing capabilities and service offerings in the North American market.